• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TPA023,一种 GABAAα2/3 激动剂,可逆转氯胺酮诱导的工作记忆损伤。

Reversal of ketamine-induced working memory impairments by the GABAAalpha2/3 agonist TPA023.

机构信息

Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06511, USA.

出版信息

Biol Psychiatry. 2010 May 15;67(10):998-1001. doi: 10.1016/j.biopsych.2010.01.001. Epub 2010 Feb 26.

DOI:10.1016/j.biopsych.2010.01.001
PMID:20189164
Abstract

BACKGROUND

Ketamine has been used to model cognitive and behavioral symptoms of schizophrenia. Current hypotheses state that inadequate glutamatergic transmission in schizophrenia leads to a deficiency in gamma-aminobutyric acid (GABA)ergic inhibitory mechanisms and treatment with a GABA type A receptor subunits alpha2/alpha3 (GABA(Aalpha2/3)) modulator improved working memory performance in a preliminary study in patients. Here, we used ketamine to impair spatial working memory and disrupt behavior to examine the capacity for the GABA(Aalpha2/3) agonist 7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine (TPA023) to reverse these symptoms.

METHODS

Rhesus monkeys received TPA023 (.7, 2.0, and 5 mg/kg; by mouth) or vehicle 45 minutes before ketamine (1.0-1.7 mg/kg; intramuscular) or saline in a semirandomized Latin square design. Behavioral observations were acquired at approximately 5 minutes, and spatial delayed response performance was tested at 15 minutes postinjection.

RESULTS

Ketamine produced a profound impairment in spatial working memory in association with the emergence of hallucinatory-like behaviors. TPA023 at all doses blocked ketamine's cognitive-impairing ability but did not influence the behavioral symptoms.

CONCLUSIONS

Acute GABA(Aalpha2/3) agonist administration reverses the working memory deficits induced by ketamine in primates. This finding indicates that the consequences of N-methyl-D-aspartate deficiency on the function of prefrontal circuits involved in working memory can be completely overcome by acute enhancement of GABA signaling.

摘要

背景

氯胺酮已被用于模拟精神分裂症的认知和行为症状。目前的假设是,精神分裂症中谷氨酸能传递不足导致γ-氨基丁酸(GABA)能抑制机制不足,而用 GABA 型 A 受体亚基 α2/α3(GABA(Aα2/3))调节剂治疗可改善初步研究中患者的工作记忆表现。在这里,我们使用氯胺酮损害空间工作记忆并破坏行为,以检查 GABA(Aα2/3)激动剂 7-(1,1-二甲基乙基)-6-(2-乙基-2H-1,2,4-三唑-3-基甲氧基)-3-(2-氟苯基)-1,2,4-三唑并[4,3-b]吡啶(TPA023)逆转这些症状的能力。

方法

恒河猴在半随机拉丁方设计中在氯胺酮(1.0-1.7mg/kg;肌肉注射)或生理盐水前 45 分钟口服接受 TPA023(0.7、2.0 和 5mg/kg)或载体。大约在 5 分钟时进行行为观察,在注射后 15 分钟时测试空间延迟反应表现。

结果

氯胺酮导致空间工作记忆严重受损,同时出现幻觉样行为。TPA023 在所有剂量下均阻断了氯胺酮的认知损害能力,但不影响行为症状。

结论

急性 GABA(Aα2/3)激动剂给药可逆转灵长类动物中氯胺酮引起的工作记忆缺陷。这一发现表明,N-甲基-D-天冬氨酸缺乏对参与工作记忆的前额叶回路功能的影响可以通过急性增强 GABA 信号完全克服。

相似文献

1
Reversal of ketamine-induced working memory impairments by the GABAAalpha2/3 agonist TPA023.TPA023,一种 GABAAα2/3 激动剂,可逆转氯胺酮诱导的工作记忆损伤。
Biol Psychiatry. 2010 May 15;67(10):998-1001. doi: 10.1016/j.biopsych.2010.01.001. Epub 2010 Feb 26.
2
TPA023 [7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an agonist selective for alpha2- and alpha3-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates.TPA023 [7-(1,1-二甲基乙基)-6-(2-乙基-2H-1,2,4-三唑-3-基甲氧基)-3-(2-氟苯基)-1,2,4-三唑并[4,3-b]哒嗪],一种对含α2和α3的GABAA受体具有选择性的激动剂,在啮齿动物和灵长类动物中是一种无镇静作用的抗焦虑药。
J Pharmacol Exp Ther. 2006 Jan;316(1):410-22. doi: 10.1124/jpet.105.089920. Epub 2005 Sep 23.
3
Prevention of ketamine-induced working memory impairments by AMPA potentiators in a nonhuman primate model of cognitive dysfunction.AMPA 增效剂预防认知功能障碍非人灵长类模型中氯胺酮引起的工作记忆损伤。
Behav Brain Res. 2010 Sep 1;212(1):41-8. doi: 10.1016/j.bbr.2010.03.039. Epub 2010 Mar 27.
4
Disruptions in spatial working memory, but not short-term memory, induced by repeated ketamine exposure.反复暴露于氯胺酮会导致空间工作记忆受损,但不会影响短期记忆。
Prog Neuropsychopharmacol Biol Psychiatry. 2009 Jun 15;33(4):668-75. doi: 10.1016/j.pnpbp.2009.03.013. Epub 2009 Mar 21.
5
Benzodiazepine binding site occupancy by the novel GABAA receptor subtype-selective drug 7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine (TPA023) in rats, primates, and humans.新型 GABAA 受体亚型选择性药物 7-(1,1-二甲基乙基)-6-(2-乙基-2H-1,2,4-三唑-3-基甲氧基)-3-(2-氟苯基)-1,2,4-三唑并[4,3-b]哒嗪(TPA023)在大鼠、灵长类动物和人类中苯二氮䓬结合位点占有率的研究。
J Pharmacol Exp Ther. 2010 Jan;332(1):17-25. doi: 10.1124/jpet.109.157909. Epub 2009 Sep 24.
6
Glycine transporter inhibition reverses ketamine-induced working memory deficits.甘氨酸转运体抑制可逆转氯胺酮诱导的工作记忆缺陷。
Neuroreport. 2010 Mar 31;21(5):390-4. doi: 10.1097/WNR.0b013e3283381a4e.
7
Metabolism and disposition of a potent and selective GABA-Aalpha2/3 receptor agonist in healthy male volunteers.一种强效且选择性的GABA-Aα2/3受体激动剂在健康男性志愿者体内的代谢与处置
Drug Metab Dispos. 2006 Jun;34(6):1004-11. doi: 10.1124/dmd.105.008193. Epub 2006 Mar 1.
8
7-(1,1-Dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine: a functionally selective gamma-aminobutyric acid(A) (GABA(A)) alpha2/alpha3-subtype selective agonist that exhibits potent anxiolytic activity but is not sedating in animal models.7-(1,1-二甲基乙基)-6-(2-乙基-2H-1,2,4-三唑-3-基甲氧基)-3-(2-氟苯基)-1,2,4-三唑并[4,3-b]哒嗪:一种功能选择性γ-氨基丁酸(A)(GABA(A))α2/α3亚型选择性激动剂,在动物模型中表现出强效抗焦虑活性但无镇静作用。
J Med Chem. 2005 Nov 17;48(23):7089-92. doi: 10.1021/jm058034a.
9
Subtype-selective GABA(A) receptor modulation yields a novel pharmacological profile: the design and development of TPA023.亚型选择性GABA(A)受体调节产生一种新型药理学特征:TPA023的设计与开发。
Adv Pharmacol. 2009;57:137-85. doi: 10.1016/S1054-3589(08)57004-9. Epub 2009 Nov 27.
10
Pharmacodynamic and pharmacokinetic effects of TPA023, a GABA(A) alpha(2,3) subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers.与劳拉西泮和安慰剂相比,GABA(A)α(2,3)亚型选择性激动剂TPA023在健康志愿者中的药效学和药代动力学效应。
J Psychopharmacol. 2007 Jun;21(4):374-83. doi: 10.1177/0269881106072343. Epub 2006 Nov 8.

引用本文的文献

1
Contribution of GABA receptor subunits to attention and social behavior.GABA 受体亚基对注意力和社会行为的贡献。
Behav Brain Res. 2020 Jan 27;378:112261. doi: 10.1016/j.bbr.2019.112261. Epub 2019 Sep 24.
2
TPA-023 attenuates subchronic phencyclidine-induced declarative and reversal learning deficits via GABA receptor agonist mechanism: possible therapeutic target for cognitive deficit in schizophrenia.TPA-023 通过 GABA 受体激动剂机制减轻慢性苯环己哌啶诱导的陈述性和反转学习缺陷:精神分裂症认知缺陷的潜在治疗靶点。
Neuropsychopharmacology. 2018 Nov;43(12):2468-2477. doi: 10.1038/s41386-018-0160-3. Epub 2018 Jul 23.
3
The effect of ketamine on the consolidation and extinction of contextual fear memory.
氯胺酮对情景恐惧记忆的巩固和消除的影响。
J Psychopharmacol. 2018 Feb;32(2):156-162. doi: 10.1177/0269881117748903. Epub 2018 Jan 17.
4
Gastrodin Attenuates Cognitive Deficits Induced by 3,3'-Iminodipropionitrile.天麻素减轻3,3'-亚氨基二丙腈诱导的认知缺陷。
Neurochem Res. 2016 Jun;41(6):1401-9. doi: 10.1007/s11064-016-1845-9. Epub 2016 Feb 11.
5
Mutations in NONO lead to syndromic intellectual disability and inhibitory synaptic defects.NONO基因的突变会导致综合征性智力障碍和抑制性突触缺陷。
Nat Neurosci. 2015 Dec;18(12):1731-6. doi: 10.1038/nn.4169. Epub 2015 Nov 16.
6
Specific Roles of NMDA Receptor Subunits in Mental Disorders.NMDA受体亚基在精神障碍中的特定作用。
Curr Mol Med. 2015;15(3):193-205. doi: 10.2174/1566524015666150330142807.
7
Behavioral effects of the benzodiazepine-positive allosteric modulator SH-053-2'F-S-CH₃ in an immune-mediated neurodevelopmental disruption model.苯二氮䓬类正变构调节剂SH-053-2'F-S-CH₃在免疫介导的神经发育破坏模型中的行为效应
Int J Neuropsychopharmacol. 2015 Jan 30;18(4):pyu055. doi: 10.1093/ijnp/pyu055.
8
Relationship between glycine transporter 1 inhibition as measured with positron emission tomography and changes in cognitive performances in nonhuman primates.通过正电子发射断层扫描测量的甘氨酸转运体1抑制与非人灵长类动物认知表现变化之间的关系。
Neuropsychopharmacology. 2014 Nov;39(12):2742-9. doi: 10.1038/npp.2014.4. Epub 2014 Feb 3.
9
Reviewing the ketamine model for schizophrenia.审视精神分裂症的氯胺酮模型。
J Psychopharmacol. 2014 Apr;28(4):287-302. doi: 10.1177/0269881113512909. Epub 2013 Nov 20.
10
GABAA receptor subtypes: Therapeutic potential in Down syndrome, affective disorders, schizophrenia, and autism.GABAA受体亚型:在唐氏综合征、情感障碍、精神分裂症和自闭症中的治疗潜力。
Annu Rev Pharmacol Toxicol. 2014;54:483-507. doi: 10.1146/annurev-pharmtox-011613-135947. Epub 2013 Oct 23.